In metastatic PC (Fig. 4), we found a significant reduction in metastatic lesions and longer overall metastatic-free survival in mice treated with 177Lu-DOTA-AE105 compared to controls, thus setting the stage for a uPAR-mediated theranostic approach [48]. Here, PLAUR is linked to pachyonychia congenita.